1. Home
  2. TSE vs STRO Comparison

TSE vs STRO Comparison

Compare TSE & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSE
  • STRO
  • Stock Information
  • Founded
  • TSE 2010
  • STRO 2003
  • Country
  • TSE United States
  • STRO United States
  • Employees
  • TSE N/A
  • STRO N/A
  • Industry
  • TSE Major Chemicals
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TSE Industrials
  • STRO Health Care
  • Exchange
  • TSE Nasdaq
  • STRO Nasdaq
  • Market Cap
  • TSE 164.3M
  • STRO 162.9M
  • IPO Year
  • TSE 2014
  • STRO 2018
  • Fundamental
  • Price
  • TSE $4.14
  • STRO $1.97
  • Analyst Decision
  • TSE
  • STRO Strong Buy
  • Analyst Count
  • TSE 0
  • STRO 7
  • Target Price
  • TSE N/A
  • STRO $12.14
  • AVG Volume (30 Days)
  • TSE 270.0K
  • STRO 851.3K
  • Earning Date
  • TSE 02-12-2025
  • STRO 03-24-2025
  • Dividend Yield
  • TSE 0.93%
  • STRO N/A
  • EPS Growth
  • TSE N/A
  • STRO N/A
  • EPS
  • TSE N/A
  • STRO N/A
  • Revenue
  • TSE $3,529,200,000.00
  • STRO $160,955,000.00
  • Revenue This Year
  • TSE N/A
  • STRO N/A
  • Revenue Next Year
  • TSE $2.74
  • STRO N/A
  • P/E Ratio
  • TSE N/A
  • STRO N/A
  • Revenue Growth
  • TSE N/A
  • STRO 230.90
  • 52 Week Low
  • TSE $1.94
  • STRO $1.67
  • 52 Week High
  • TSE $7.05
  • STRO $6.13
  • Technical
  • Relative Strength Index (RSI)
  • TSE 36.68
  • STRO 42.67
  • Support Level
  • TSE $3.90
  • STRO $1.81
  • Resistance Level
  • TSE $4.29
  • STRO $2.01
  • Average True Range (ATR)
  • TSE 0.22
  • STRO 0.14
  • MACD
  • TSE -0.04
  • STRO 0.03
  • Stochastic Oscillator
  • TSE 17.17
  • STRO 47.92

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include latex binders, feedstocks, polystyrene, Americas styrenics, engineered materials, and plastics solutions. Majority of the revenue is generated from its Polystyrene segment which provides a variety of general purpose polystyrenes, and high impact polystyrene. These products provide customers with performance and aesthetics at a relatively low cost across applications, including appliances, packaging, including food packaging and food service disposables, consumer electronics and building and construction materials. Geographically, the company generates majority of the revenue from Europe and also has its presence in United States, Asia-Pacific and other regions.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

Share on Social Networks: